Ubiquitination: Friend and foe in cancer
- PMID: 29864543
- DOI: 10.1016/j.biocel.2018.06.001
Ubiquitination: Friend and foe in cancer
Abstract
Dynamic modulation and posttranslational modification of proteins are tightly controlled biological processes that occur in response to physiological cues. One such dynamic modulation is ubiquitination, which marks proteins for degradation via the proteasome, altering their localization, affecting their activity, and promoting or interfering with protein interactions. Hence, ubiquitination is crucial for a plethora of physiological processes, including cell survival, differentiation and innate and adaptive immunity. Similar to kinases, components of the ubiquitination system are often deregulated, leading to a variety of diseases, such as cancer and neurodegenerative disorders. In a context-dependent manner, ubiquitination can regulate both tumor-suppressing and tumor-promoting pathways in cancer. This review outlines how components of the ubiquitination systems (e.g. E3 ligases and deubiquitinases) act as oncogenes or tumor suppressors according to the nature of their substrates. Furthermore, I interrogate how the current knowledge of the differential roles of ubiquitination in cancer lead to technical advances to inhibit or reactivate the components of the ubiquitination system accordingly.
Keywords: Cancer; Deubiquitinating enzyme; E3 ligases; Hydrophobic tag; MDM2; P53; PROTAC; SCF complex; ubiquitin–proteasome system.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Dysregulation of ubiquitin ligases in cancer.Drug Resist Updat. 2015 Nov;23:1-11. doi: 10.1016/j.drup.2015.09.001. Epub 2015 Sep 28. Drug Resist Updat. 2015. PMID: 26690337 Free PMC article. Review.
-
[The role of different E3 ubiquitin ligases in regulation of the P53 tumor suppressor protein].Tsitologiia. 2013;55(10):673-87. Tsitologiia. 2013. PMID: 25509121 Review. Russian.
-
Role of the ubiquitin proteasome system in hematologic malignancies.Immunol Rev. 2015 Jan;263(1):224-39. doi: 10.1111/imr.12236. Immunol Rev. 2015. PMID: 25510280 Review.
-
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches.Mol Cancer. 2024 Jul 25;23(1):148. doi: 10.1186/s12943-024-02046-3. Mol Cancer. 2024. PMID: 39048965 Free PMC article. Review.
-
The role of aberrant proteolysis in lymphomagenesis.Curr Opin Hematol. 2015 Jul;22(4):369-78. doi: 10.1097/MOH.0000000000000156. Curr Opin Hematol. 2015. PMID: 26049759 Free PMC article. Review.
Cited by
-
RNF2 promotes chondrosarcoma progression by regulating ubiquitination and degradation of CBX7.Cancer Metab. 2024 Oct 25;12(1):30. doi: 10.1186/s40170-024-00359-x. Cancer Metab. 2024. PMID: 39456039 Free PMC article.
-
MiR-337-3p confers protective effect on facet joint osteoarthritis by targeting SKP2 to inhibit DUSP1 ubiquitination and inactivate MAPK pathway.Cell Biol Toxicol. 2023 Jun;39(3):1099-1118. doi: 10.1007/s10565-021-09665-2. Epub 2021 Oct 25. Cell Biol Toxicol. 2023. PMID: 34697729
-
Increased FUN14 domain containing 1 (FUNDC1) ubiquitination level inhibits mitophagy and alleviates the injury in hypoxia-induced trophoblast cells.Bioengineered. 2022 Feb;13(2):3620-3633. doi: 10.1080/21655979.2021.1997132. Bioengineered. 2022. PMID: 34699308 Free PMC article.
-
Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients.Pathol Oncol Res. 2021 Oct 29;27:1609941. doi: 10.3389/pore.2021.1609941. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34776794 Free PMC article.
-
The ubiquitin codes in cellular stress responses.Protein Cell. 2024 Feb 29;15(3):157-190. doi: 10.1093/procel/pwad045. Protein Cell. 2024. PMID: 37470788 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous